Morgens Waterfall Vintiadis & CO Inc Crispr Therapeutics Ag Transaction History

Morgens Waterfall Vintiadis & CO Inc

  • $118 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$33.68 - $62.53 $336,800 - $625,300
-10,000 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$23.52 - $58.17 $470,400 - $1.16 Million
-20,000 Reduced 66.67%
10,000 $457,000
Q4 2017

Feb 14, 2018
BUY
$16.95 - $23.48 $508,500 - $704,400
30,000
30,000 $704,000

Others Institutions Holding CRSP

# of Institutions
489
Shares Held
57.9M
Call Options Held
1.09M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.16B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Morgens Waterfall Vintiadis & CO Inc Portfolio

Follow Morgens Waterfall Vintiadis & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email